Mary Ann Hardwicke

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo et al. · Proceedings of the National Academy of Sciences · 2011 · 501 citations

Drug Target, Breast Oncology, Chemoprevention Strategy +17

Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression

Irene L. Smith, Mary Ann Hardwicke, Rozanne M. Sandri-Goldin · Virology · 1992 · 281 citations

Transcriptional Regulation, Viral Replication, Early Protein Icp27 +9

The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection

Mary Ann Hardwicke, Rozanne M. Sandri-Goldin · Journal of Virology · 1994 · 189 citations · Full text

Viral Replication, Icp27 Viral Mutants, Immunology +17

Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers

Wenle Xia, John Bisi, Jay C. Strum et al. · Cancer Research · 2006 · 151 citations

The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however, these alterations are not sufficient to inhibit host cell splicing

Rozanne M. Sandri-Goldin, M K Hibbard, Mary Ann Hardwicke · Journal of Virology · 1995 · 131 citations · Full text

Viral Replication, Immediate-early Protein Icp27, Immunology +16